p70(S6K) Monoclonal antibody
p70(S6K) Monoclonal Antibody for IHC, WB, ELISA
Host / Isotype
Mouse / IgG1
Human, Mouse, Rat and More (2)
WB, IHC, ELISA
Cat no : 66638-1-Ig
|Positive WB detected in||Jurkat cells, HEK-293 cells, HSC-T6 cells, NIH/3T3 cells|
|Positive IHC detected in||human lung cancer tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Western Blot (WB)||WB : 1:1000-1:6000|
|Immunohistochemistry (IHC)||IHC : 1:200-1:800|
|Sample-dependent, check data in validation data gallery|
66638-1-Ig targets p70(S6K) in WB, IHC, ELISA applications and shows reactivity with Human, Mouse, Rat samples.
|Tested Reactivity||Human, Mouse, Rat|
|Cited Reactivity||human, mouse|
|Host / Isotype||Mouse / IgG1|
|Immunogen||p70(S6K) fusion protein Ag5883|
|Full Name||ribosomal protein S6 kinase, 70kDa, polypeptide 1|
|Calculated molecular weight||59 kDa|
|Observed molecular weight||60-75 kDa|
|GenBank accession number||BC053365|
|Gene ID (NCBI)||6198|
|Purification Method||Protein G purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.|
RPS6KB1(Ribosomal protein S6 kinase beta-1) is also named as STK14A, p70 S6KA and belongs to the S6 kinase subfamily. RPS6KB1 is a major substrate of MTOR and acts as a crucial effector of MTOR signaling pathway. It plays a key role in cell growth and proliferation by regulating INS sensitivity, metabolism, protein synthesis, and cell cycle. RPS6KB1 may play an important role in the progression of HCC and could serve as a potential molecular target for HCC therapy (PMID:22684641). RPS6KB1 is a 70 kDa protein and has 5 isoforms with the calculated molecular mass of 51-59kDa produced by alternative initiation.
|Product Specific Protocols|
|WB protocol for p70(S6K) antibody 66638-1-Ig||Download protocol|
|IHC protocol for p70(S6K) antibody 66638-1-Ig||Download protocol|
|Click here to view our Standard Protocols|
OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Cancer Commun (Lond)
KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.
Helicobacter urease suppresses cytotoxic CD8 + T cell responses through activating Myh9-dependent induction of PD-L1.
Clin Transl Oncol
PRDX2 plays an oncogenic role in esophageal squamous cell carcinoma via Wnt/β-catenin and AKT pathways.
Exp Mol Pathol
RabGEF1 functions as an oncogene in U251 glioblastoma cells and is involved in regulating AKT and Erk pathways.
Cancer Manag Res
siPRDX2-elevated DNM3 inhibits the proliferation and metastasis of colon cancer cells via AKT signaling pathway.